Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
EyePoint Pharmaceuticals | Buy | $20 | |
Pyxis Oncology | Buy | $8 | |
Surrozen | Buy | $54 | |
Clinigence Holdings | Buy | $306 | |
Flywire | Buy | ― | |
Metals Royalty Company Inc. | Buy | ― | |
Autoliv | Buy | $139 | |
Microsoft | Buy | $640 | |
Ocular Therapeutix | Buy | ― |
Analyst & Firm | Company | Rating | Price Target |
|---|---|---|---|
EyePoint Pharmaceuticals | Buy | $20 | |
Pyxis Oncology | Buy | $8 | |
Surrozen | Buy | $54 | |
Clinigence Holdings | Buy | $306 | |
Flywire | Buy | ― | |
Metals Royalty Company Inc. | Buy | ― | |
Autoliv | Buy | $139 | |
Microsoft | Buy | $640 | |
Ocular Therapeutix | Buy | ― |